These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32115350)

  • 21. Tanshinone IIA Prevents Leu27IGF-II-Induced Cardiomyocyte Hypertrophy Mediated by Estrogen Receptor and Subsequent Akt Activation.
    Weng YS; Wang HF; Pai PY; Jong GP; Lai CH; Chung LC; Hsieh DJ; HsuanDay C; Kuo WW; Huang CY
    Am J Chin Med; 2015; 43(8):1567-91. PubMed ID: 26621443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corrigendum to "Zerumbone enhances the Th1 response and ameliorates ovalbumin-induced Th2 responses and airway inflammation in mice" [Int. Immunopharmacol. 24 (2015) 383-391].
    Shieh YH; Huang HM; Ching-Chiung Wang ; Lee CC; Fan CK; Lee YL
    Int Immunopharmacol; 2017 Sep; 50():371. PubMed ID: 28751107
    [No Abstract]   [Full Text] [Related]  

  • 23. Corrigendum to "Schizandrin inhibits fibrosis and epithelial-mesenchymal transition in transforming growth factor-β1-stimulated AML12 cells" [Int. Immunopharmacol. 25 (2015) 276-284].
    Park JH; Yoon J
    Int Immunopharmacol; 2020 Aug; 85():106747. PubMed ID: 32616385
    [No Abstract]   [Full Text] [Related]  

  • 24. Corrigendum to "Echistatin/BYL-719 impedes epithelial-mesenchymal transition in pulmonary fibrosis induced by silica through modulation of the Integrin β1/ILK/PI3K signaling pathway" [Int. Immunopharmacol. 136 (2024) 112368].
    Li H; Wang P; Hu M; Xu S; Li X; Xu D; Feng K; Zhou Q; Chang M; Yao S
    Int Immunopharmacol; 2024 Aug; 137():112502. PubMed ID: 38902128
    [No Abstract]   [Full Text] [Related]  

  • 25. Activation of Akt-mTOR-p70S6K pathway in angiogenesis in hepatocellular carcinoma.
    Li W; Tan D; Zhang Z; Liang JJ; Brown RE
    Oncol Rep; 2008 Oct; 20(4):713-9. PubMed ID: 18813808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tanshinone IIA prevents doxorubicin-induced cardiomyocyte apoptosis through Akt-dependent pathway.
    Hong HJ; Liu JC; Chen PY; Chen JJ; Chan P; Cheng TH
    Int J Cardiol; 2012 May; 157(2):174-9. PubMed ID: 21190747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tanshinone IIA inhibits angiogenesis in human endothelial progenitor cells
    Lee HP; Liu YC; Chen PC; Tai HC; Li TM; Fong YC; Chang CS; Wu MH; Chiu LP; Wang CJ; Chen YH; Wu YJ; Tang CH; Wang SW
    Oncotarget; 2017 Dec; 8(65):109217-109227. PubMed ID: 29312602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Corrigendum to "Rotundic acid ameliorates non-alcoholic steatohepatitis via SREBP-1c/SCD1 signaling pathway and modulating gut microbiota" [Int. Immunopharmacol. 99 (2021) 108065].
    Liu HJ; Cao ST; Wen BY; Han X; Li Y; Li S; Li J; Zhang L
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111084. PubMed ID: 37879973
    [No Abstract]   [Full Text] [Related]  

  • 29. Corrigendum to "Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function" [Int. Immunopharmacol. (2015) 423-432].
    Sun J; Shen X; Dong J; Zhao J; Zuo L; Wang H; Li Y; Zhu W; Gong J; Li J
    Int Immunopharmacol; 2016 Jun; 35():341. PubMed ID: 27130814
    [No Abstract]   [Full Text] [Related]  

  • 30. Corrigendum to "Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways". [Int. Immunopharmacol. 66 (2019) 41-51].
    Huang Q; Zhang X; Bai F; Nie J; Wen S; Wei Y; Wei J; Huang R; He M; Lu Z; Lin X
    Int Immunopharmacol; 2020 Feb; 79():106117. PubMed ID: 31862426
    [No Abstract]   [Full Text] [Related]  

  • 31. Tanshinone IIA attenuates TNF-α induced PTX3 expression and monocyte adhesion to endothelial cells through the p38/NF-κB pathway.
    Fang J; Chen Q; He B; Cai J; Yao Y; Cai Y; Xu S; Rengasamy KRR; Gowrishankar S; Pandian SK; Cao T
    Food Chem Toxicol; 2018 Nov; 121():622-630. PubMed ID: 30268796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tanshinone IIA inhibits TNF-α-mediated induction of VCAM-1 but not ICAM-1 through the regulation of GATA-6 and IRF-1.
    Nizamutdinova IT; Kim YM; Jin H; Son KH; Lee JH; Chang KC; Kim HJ
    Int Immunopharmacol; 2012 Dec; 14(4):650-7. PubMed ID: 23085565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tanshinone IIA decreases the protein expression of EGFR, and IGFR blocking the PI3K/Akt/mTOR pathway in gastric carcinoma AGS cells both in vitro and in vivo.
    Su CC; Chiu TL
    Oncol Rep; 2016 Aug; 36(2):1173-9. PubMed ID: 27277844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tanshinone IIA Affects Autophagy and Apoptosis of Glioma Cells by Inhibiting Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway.
    Ding L; Ding L; Wang S; Wang S; Wang W; Wang W; Lv P; Lv P; Zhao D; Zhao D; Chen F; Chen F; Meng T; Meng T; Dong L; Dong L; Qi L; Qi L
    Pharmacology; 2017; 99(3-4):188-195. PubMed ID: 27889779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corrigendum to 'Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways'. [Int. Immunopharmacol. 75 (2019) 105739].
    Li Y; Zeng Y; Meng T; Gao X; Huang B; He D; Ran X; Du J; Zhang Y; Fu S; Hu G
    Int Immunopharmacol; 2020 Jul; 84():105962. PubMed ID: 31948857
    [No Abstract]   [Full Text] [Related]  

  • 36. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Corrigendum to "In vivo anti-apoptosis activity of novel berberine-loaded chitosan nanoparticles effectively ameliorates osteoarthritis" [Int. Immunopharmacol. 28(1) (2015) 34-43].
    Zhou Y; Liu SQ; Peng H; Yu L; He B; Zhao Q
    Int Immunopharmacol; 2020 Sep; 86():106796. PubMed ID: 32674050
    [No Abstract]   [Full Text] [Related]  

  • 38. Silencing of angiotensin II type-1 receptor inhibits high glucose-induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells via inactivation of mTOR/p70S6K signaling pathway.
    Gong Q; Hou F
    Biochem Biophys Res Commun; 2016 Jan; 469(2):183-8. PubMed ID: 26626074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corrigendum to "Oleamide suppresses inflammatory responses in LPS-induced RAW264.7 murine macrophages and alleviates paw edema in a carrageenan-induced inflammatory rat model" [Int. Immunopharmacol. 56 (2018) 179-185].
    Moon SM; Lee SA; Hong JH; Kim JS; Kim DK; Kim CS
    Int Immunopharmacol; 2018 Jul; 60():246. PubMed ID: 29789261
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease.
    Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M
    Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.